Chambers Michael Andrew's Form 4 filing
Sarepta Therapeutics, Inc. (SRPT) · filed Sep 15, 2022
- Accession no.
- 0001209191-22-050002
- Filed
- Sep 15, 2022
- Trade date
- Sep 14, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.96M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chambers Michael AndrewCIK 0001932527 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | Common Stock | PPurchaseAcquired | +20,744 | $103.87 | +$2,154,679.28 | 71,822 | Direct | |
| Sep 14, 2022 | Common Stock | PPurchaseAcquired | +30,106 | $104.67 | +$3,151,195.02 | 101,928 | Direct | |
| Sep 14, 2022 | Common Stock | PPurchaseAcquired | +6,250 | $105.16 | +$657,250 | 108,178 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.